REALIZE ADJUSTABLE GASTRIC BAND MODEL 2200-X

FDA Premarket Approval P070009

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the realize adjustable gastric band. This device is indicated for weight reduction for morbidly obese patients and is indicated for individuals with a body mass index (bmi) of at least 40 kg/m2, or a bmi of at least 35 kg/m2 with one or more comorbid conditions. The band is indicated for use only in morbidly obese adult patients who have failed more conservative weight-reduction alternatives, such as supervised diet, exercise and behavior modification programs.

DeviceREALIZE ADJUSTABLE GASTRIC BAND MODEL 2200-X
Generic NameImplant, Intragastric For Morbid Obesity
ApplicantOBTECH MEDICAL GMBH
Date Received2007-04-02
Decision Date2007-09-28
Notice Date2007-11-09
PMAP070009
SupplementS
Product CodeLTI 
Docket Number07M-0380
Advisory CommitteeGastroenterology/Urology
Expedited ReviewNo
Combination Product No
Applicant Address OBTECH MEDICAL GMBH landis And Gyr Strasse 1 zug CH-63-6300
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P070009Original Filing
S017 2016-06-21 Normal 180 Day Track No User Fee
S016 2016-04-21 Normal 180 Day Track No User Fee
S015 2015-03-09 30-day Notice
S014 2011-11-04 30-day Notice
S013 2011-02-08 Real-time Process
S012 2011-02-08 135 Review Track For 30-day Notice
S011 2011-01-18 Normal 180 Day Track
S010 2010-06-29 30-day Notice
S009 2010-05-07 Special (immediate Track)
S008 2010-06-07 Real-time Process
S007 2009-12-22 135 Review Track For 30-day Notice
S006 2009-09-08 30-day Notice
S005 2009-07-29 30-day Notice
S004 2008-09-29 135 Review Track For 30-day Notice
S003 2008-04-18 Normal 180 Day Track
S002 2008-03-13 30-day Notice
S001 2007-10-29 Normal 180 Day Track No User Fee

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.